One of the most widely used chemotherapeutic agents for colorectal cancer is 5-fluorouracil (5-FU), a cornerstone treatment ...

Immunotherapy wipes out some colorectal tumors without surgery, signaling a major shift toward less invasive treatment.

One of the most widely used chemotherapeutic agents for colorectal cancer is 5-fluorouracil (5-FU), a cornerstone treatment ...

Adding encorafenib and cetuximab to chemotherapy backbone also prolonged overall survival ...

"ASCO 2026: Interim data released for upcoming BRAF and RAS mCRC therapies" was originally created and published by Clinical ...

Human epidermal growth factor receptor 2 (HER2) is a transmembrane tyrosine kinase receptor whose amplification or overexpression drives tumour cell proliferation and survival. In metastatic ...

Metastatic colorectal cancer (mCRC) remains a leading cause of cancer mortality, driving continual refinement of first-line treatment strategies. Progress in molecular profiling has enabled ...

Colon cancer diagnosis involves colonoscopy, imaging, and blood tests, with staging guiding treatment decisions. Stage 1 treatment typically involves surgery, while stage 2 may include chemotherapy ...

Time Toxicity in Patients With Advanced Biliary Tract Cancer Receiving Gemcitabine Plus Cisplatin With or Without Durvalumab Most patients with metastatic colorectal cancer (CRC) have microsatellite ...

The authors of the publication, from left to right: Maria Navarro, PhD, former member of the CGE, IGTP, currently working at Ability Pharmaceuticals, Nuria Mulet, MD PhD (ICO, B-ARGO), Cinta Hierro, ...

Approximately 25% of patients with colorectal cancer present with metastatic disease to the liver at diagnosis, and about 50% develop liver metastases at some point during the course of the disease.